Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2010 Jul 12;24(4):269–272. doi: 10.1002/jcla.20398

Celiac disease‐associated antibodies in patients with psoriasis and correlation with HLA Cw6

Sangeeta Singh 1,✉, Gyanendra Kumar Sonkar 2, Usha 1, Sanjay Singh 3
PMCID: PMC6647658  PMID: 20626025

Abstract

Etiopathology of psoriasis is not completely understood. Patients with psoriasis show elevated sensitivity to gluten. The aim of this study was to see the expression of celiac disease (CD)‐associated antibodies gliadin IgA, gliadin IgG, and tissue transglutaminase IgA, and their correlation with HLA Cw6 in patients with psoriasis. The study comprised 56 patients with psoriasis and 60 healthy controls (HC). The levels of antibodies were detected by using ELISA technique and HLA Cw6 typing was carried out by microcytotoxicity method. HLA Cw6 was significantly expressed in psoriasis cases when compared with HC (P<0.05). CD‐associated antibodies gliadin IgA/IgG and tissue transglutaminase IgA were significantly higher in the serum of patient with psoriasis when compared with HC (P<0.05, <0.05, and 0.01, respectively). Serum anti tissue transglutaminase IgA (anti tTG IgA) was significantly higher in females when compared with males and expressed more in elderly patients. There was a significant positive correlation among the antibodies (anti gliadin IgA with anti gliadin IgG: r=0.67, P<0.05; anti gliadin IgA with anti tTG IgA: r=0.45, P<0.05, anti gliadin IgG with anti tTG IgA: r=0.26, P<0.05, respectively), whereas insignificant with HLA Cw6. Our study concludes that latent CD or CD‐associated antibodies were present in patients with psoriasis and also concludes that HLA Cw6 has no association with expression of these antibodies in patients with psoriasis. J. Clin. Lab. Anal. 24:269–272, 2010. © 2010 Wiley‐Liss, Inc.

Keywords: psoriasis, celiac disease, anti gliadin IgA, anti gliadin IgG, anti tissue transglutaminase IgA

REFERENCES

  • 1. Wolters M. Diet and psoriasis: Experimental data and clinical evidence. Br J Dermatol 2005;153:706–714. [DOI] [PubMed] [Google Scholar]
  • 2. Bianchi L, Farrace MG, Nini G, Piacentini M. Abnormal Bcl‐2 and “tissue” transglutaminase expression in psoriasis skin. J Invest Dermatol 1994;103:829–833. [DOI] [PubMed] [Google Scholar]
  • 3. Michaelsson G, Gerden B, Hagforsen E, et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten‐free diet. Br J Dermatol 2000;142:44–51. [DOI] [PubMed] [Google Scholar]
  • 4. Lindqvist U, Rudsander A, Bostrom A, Nilsson B, Michaelsson G. IgA antibodies to gliadin and CD in psoriatic arthritis. Rheumatology 2002;4:31–37. [DOI] [PubMed] [Google Scholar]
  • 5. Woo WK, McMillan SA, Watson RGP, et al. CD‐associated antibodies correlate with psoriasis activity. Br J Dermatol 2004;15:891–894. [DOI] [PubMed] [Google Scholar]
  • 6. Kia KF, Nair RP, Ike RW, Hiremagalore R, Elder JT, Ellis CN. Prevalence of antigliadin antibodies in patients with psoriasis is not elevated compared with controls. Am J Clin Dermatol 2007;8:301–305. [DOI] [PubMed] [Google Scholar]
  • 7. Marks J, Shuster S. Psoriatic enteropathy. Arch Dermatol 1971;103:676–678. [PubMed] [Google Scholar]
  • 8. Michaelsson G, Ash S, Hammarstrom I, Lundin IP, Hagforsen E. Gluten‐free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67z cells in the dermis. Acta Derm Venereol 2003;83:425–429. [DOI] [PubMed] [Google Scholar]
  • 9. Corazza GR, Gasbarrini G. Coeliac disease in adults. Baillieres Clin Gastroenterol 1995;9:329–350. [DOI] [PubMed] [Google Scholar]
  • 10. Dieterich W, Esslinger B, Trapp D, et al. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut 2006;55:478–484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Nickoloff BJ. The immunologic amd genetic basis of psoriasis. Arch Dermatol 1999;135:1104–1110. [DOI] [PubMed] [Google Scholar]
  • 12. Veal CD, Capon F, Allen MH, et al. Family based analysis using a dense single‐nucleotide polymorphism‐based map defines genetic variation at PSORS1, the major psoriasis‐susceptibility locus. Am J Hum Genet 2002;71:554–564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;204:998–1000. [DOI] [PubMed] [Google Scholar]
  • 14. Mehra NK. Basic methods in HLA‐DNA technology Technical Manual Published During the DBT Sponsored Training Workshop on HLA‐DNA Technology. New Delhi: Sagar Publishers, 1989. [Google Scholar]
  • 15. Connon JJ. CD In: Shils ME, Olson JA, Shike M, Ross AC, editors. Modern Nutrition in Health and Disease, 9th edn Baltimore: Williams & Wilkins; 1999. p 1163–1168. [Google Scholar]
  • 16. Baum C, Moxon D, Scott M. Gastrointestinal disease In: Bowman BA, Russell RM, editors. Present Knowledge in Nutrition. Washington, DC: ILSI Press; 2001. p 472–482. [Google Scholar]
  • 17. Addolorato G, Parente A, de Lorenzi G, et al. Rapid regression of psoriasis in a coeliac patient after gluten free diet. Digestion 2003;68:9–12. [DOI] [PubMed] [Google Scholar]
  • 18. Michaelsson G, Kraaz W, GerdeÂn B, et al. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin. Br J Dermatol 1993;129:66–73. [DOI] [PubMed] [Google Scholar]
  • 19. Cardinali C, Degl'innocenti D, Caproni M, Fabbri P. Is the search for serum antibodies to gliadin, endomysium and tissue transglutaminase meaningful in psoriatic patients? Relationship between thepathogenesis of psoriasis and CD. Br J Dermatol 2002;147:187–188. [DOI] [PubMed] [Google Scholar]
  • 20. Damasiewicz‐Bodzek A, Wielkoszyński T. Serologic markers of CD in psoriatic patients. J Euro Acad Dermatol Venereol 2008;22:1055–1061. [DOI] [PubMed] [Google Scholar]
  • 21. Winklhofer‐Roob BM, Rossipal E, Lanzer G. Human leucocyte class I and II antigens in coeliac disease:a study in an Austrian paediatric population. Eur J Pediatr 1991;150:704–707. [DOI] [PubMed] [Google Scholar]
  • 22. DeMarchi M, Carbonara A, Ansaldi N, et al. HLA‐DR3 and DR7 in coeliac disease: immunogenetic and clinical aspects. Gut 1983;24:706–712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Brautbar C, Freier S, Ashkenazi A, et al. Histocompatibility determinants in Israeli Jewish patients with coeliac disease: Population and family study. Tissue Antigens 1981;17:313–322. [DOI] [PubMed] [Google Scholar]
  • 24. Schon MP, Boehnecke H. Psoriasis. N Engl J Med 2005;352:1899–1912. [DOI] [PubMed] [Google Scholar]
  • 25. Schuppan D. Current concepts of CD pathogenesis. Gastroenterology 2000;119:234–242. [DOI] [PubMed] [Google Scholar]
  • 26. Fogh K, Kragballe K. New vitamin D analogs in psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:199–204. [DOI] [PubMed] [Google Scholar]
  • 27. Holick MF. Vitamin D: A millennium perspective. J Cell Biochem 2003;88:296–307. [DOI] [PubMed] [Google Scholar]
  • 28. Capristo E, Addolorato G, Mingrone G, et al. Changes in body composition, substrate oxidation, and resting metabolic rate in adult celiac disease patients after a 1‐y gluten‐free diet treatment. Am J Clin Nutr 2000;72:76–81. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES